News

The company said this could open the door for ... will face competition after its patent expires in 2028. A Merck logo is shown on a scientist's lab coat. The Food and Drug Administration, on ...
In recognition of World Cloud Security Day on April 3rd, Genetec Inc. ("Genetec"), the global leader in enterprise physical security software, shares key insights and best practices to help ...
AstraZenca is testing a once-daily PCSK9 inhibitor, currently known as AZD0780. After 12 weeks of use alongside standard ...
A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...
NEW YORK, NY / ACCESS Newswire / April 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Merck & Co. Inc. closed 41.19% below its 52-week high of $134.63, which the company reached on June 25th.
We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...
In 2010, Merck bought back the plant after selling it to a contract manufacturer in 2008. Prior to the plant sale, the company had operated the site for 58 years. Merck has an overall Pennsylvania ...
The company said this could open the door for other cancers treated by Keytruda and potentially give Merck a new product at a time when the drug, which brought in nearly $30 billion in revenue in ...
Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...